MedPath

Safety of Pregnancy in BRCA Mutated Breast Cancer Patients

Completed
Conditions
Breast Cancer
Interventions
Other: Clinical outcomes
Registration Number
NCT03673306
Lead Sponsor
Jules Bordet Institute
Brief Summary

The present study aims at refining the understanding of the effect of pregnancy on breast cancer outcomes in the specific population of BRCA mutated patients with known history of breast cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
4732
Inclusion Criteria
  • Diagnosis of invasive breast cancer between January 2000 and December 2020;
  • Breast cancer diagnosis at the age of โ‰ค 40 years;
  • Known presence of germline BRCA mutation.
Exclusion Criteria
  • Known BRCA mutation with no diagnosis of invasive breast cancer;
  • Diagnosis of ovarian cancer or other malignancies with no history of invasive breast cancer;
  • Diagnosis of hereditary or familiar invasive breast cancer without BRCA mutation or with BRCA genes not tested;
  • Diagnosis of invasive breast cancer with germline BRCA variants of unknown significance.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pregnant cohortClinical outcomesWomen with one or more pregnancies any time after breast cancer diagnosis
Non-pregnant cohortClinical outcomesWomen with no subsequent pregnancies after breast cancer diagnosis
Primary Outcome Measures
NameTimeMethod
Disease-free Survival10 years

The primary end points were the cumulative incidence of pregnancy and disease-free survival.

Cumulative Incidence of Pregnancy After Breast Cancer10 years

The primary end points were the cumulative incidence of pregnancy and disease-free survival.

Secondary Outcome Measures
NameTimeMethod
Breast Cancer-Specific Survival10 years

A breast cancer-specific survival event was defined as death due to breast cancer, and patients who died for reasons other than breast cancer were censored at the date of death.

Overall Survival10 years

An overall survival event was defined as death due to any cause.

Trial Locations

Locations (81)

Yale University

๐Ÿ‡บ๐Ÿ‡ธ

New Haven, Connecticut, United States

Michigan State University

๐Ÿ‡บ๐Ÿ‡ธ

Lansing, Michigan, United States

Mayo Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, Minnesota, United States

Cleveland Clinic Taussig Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

Lifespan Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Providence, Rhode Island, United States

Hospital Aleman

๐Ÿ‡ฆ๐Ÿ‡ท

Buenos Aires, Argentina

Hospital Italiano de Buenos Aires

๐Ÿ‡ฆ๐Ÿ‡ท

Buenos Aires, Argentina

Instituto Alexander Fleming

๐Ÿ‡ฆ๐Ÿ‡ท

Buenos Aires, Argentina

University of North Carolina - Lineberger Comprehensive Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Chapel Hill, North Carolina, United States

kConFab, Follow-up Project

๐Ÿ‡ฆ๐Ÿ‡บ

Melbourne, Victoria, Australia

Peter MacCallum Cancer Centre

๐Ÿ‡ฆ๐Ÿ‡บ

Melbourne, Victoria, Australia

Medical University of Vienna

๐Ÿ‡ฆ๐Ÿ‡น

Vienna, Austria

Clinical Center University of Sarajevo

๐Ÿ‡ง๐Ÿ‡ฆ

Sarajevo, Bosnia and Herzegovina

Hospital Sรญrio-Libanรชs

๐Ÿ‡ง๐Ÿ‡ท

Brasilia, Brazil

Mc Gill University

๐Ÿ‡จ๐Ÿ‡ฆ

Montrรฉal, Canada

Todua Clinic

๐Ÿ‡ฌ๐Ÿ‡ช

Tiflis, Georgia

Universitรคtsklinikum Hamburg-Eppendorf

๐Ÿ‡ฉ๐Ÿ‡ช

Hamburg, Germany

Leitung, Brustzentrum der Universitรคt Mรผnchen (LMU)

๐Ÿ‡ฉ๐Ÿ‡ช

Mรผnchen, Germany

Tata Memorial Centre

๐Ÿ‡ฎ๐Ÿ‡ณ

Mumbai, India

Davidoff Cancer Center - Rabin Medical Center - Beilinson

๐Ÿ‡ฎ๐Ÿ‡ฑ

Petah Tikva, Israel

Universitร  Politecnica delle Marche - Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I - GM Lancisi - G Salesi

๐Ÿ‡ฎ๐Ÿ‡น

Ancona, Italy

Azienda Ospedaliero Universitaria di Cagliari

๐Ÿ‡ฎ๐Ÿ‡น

Cagliari, Italy

Florence University Hospital - University of Florence

๐Ÿ‡ฎ๐Ÿ‡น

Florence, Italy

Azienda USL Toscana Sud Est - Misericordia Hospital

๐Ÿ‡ฎ๐Ÿ‡น

Grosseto, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori

๐Ÿ‡ฎ๐Ÿ‡น

Milan, Italy

IRCCS Ospedale San Raffaele

๐Ÿ‡ฎ๐Ÿ‡น

Milan, Italy

IRCCS Ospedale Policlinico San Martino

๐Ÿ‡ฎ๐Ÿ‡น

Genova, Italy

San Gerardo Hospital ASST Monza

๐Ÿ‡ฎ๐Ÿ‡น

Monza, Italy

University of Naples "Federico II"

๐Ÿ‡ฎ๐Ÿ‡น

Naples, Italy

IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori

๐Ÿ‡ฎ๐Ÿ‡น

Meldola, Italy

Azienda Ospedaliero Universitaria Pisana - Ospedale Santa Chiara

๐Ÿ‡ฎ๐Ÿ‡น

Pisa, Italy

Nuovo Ospedale di Prato - Santo Stefano

๐Ÿ‡ฎ๐Ÿ‡น

Prato, Italy

ASL Roma 1 - Centro Oncologico S. Spirito - Nuovo Regina Margherita

๐Ÿ‡ฎ๐Ÿ‡น

Rome, Italy

Policlinico Universitario Agostino Gemelli IRCCS

๐Ÿ‡ฎ๐Ÿ‡น

Rome, Italy

University of Ulsan, College of Medicine, Asan medical center

๐Ÿ‡ฐ๐Ÿ‡ท

Seoul, Korea, Republic of

Saint Joseph University of Beirut

๐Ÿ‡ฑ๐Ÿ‡ง

Beirut, Lebanon

Hospital Zambrano Hellion - Tecnologico de Monterrey

๐Ÿ‡ฒ๐Ÿ‡ฝ

Monterrey, Mexico

Netherlands Cancer Institute

๐Ÿ‡ณ๐Ÿ‡ฑ

Amsterdam, Netherlands

Medical University of Gdansk

๐Ÿ‡ต๐Ÿ‡ฑ

Gdaล„sk, Poland

Poznan University of Medical Sciences, University Hospital of H. Swiecicki

๐Ÿ‡ต๐Ÿ‡ฑ

Poznaล„, Poland

Military institute of Medicine

๐Ÿ‡ต๐Ÿ‡ฑ

Warsaw, Poland

Champalimaud Foundation

๐Ÿ‡ต๐Ÿ‡น

Lisboa, Portugal

Institute of Oncology "Ion Chiricuta"

๐Ÿ‡ท๐Ÿ‡ด

Cluj-Napoca, Romania

Institute for Oncology and Radiology of Serbia

๐Ÿ‡ท๐Ÿ‡ธ

Belgrade, Serbia

Oncology Institute of Vojvodina - University of Novi Sad

๐Ÿ‡ท๐Ÿ‡ธ

Novi Sad, Serbia

St. Elisabeth Cancer Institute (Onkologicky ustav sv. Alzbety-OUSA)

๐Ÿ‡ธ๐Ÿ‡ฐ

Bratislava, Slovakia

Hospital Clรญnic of Barcelona

๐Ÿ‡ช๐Ÿ‡ธ

Barcelona, Spain

Hospital Universitario 12 de Octubre

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

Ramon y Cajal - IOB Institute of Oncology (Madrid) - International Breast Cancer Center (IBCC)

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

Capio Saint Gรถran's Hospital

๐Ÿ‡ธ๐Ÿ‡ช

Stockholm, Sweden

Karolinska University Hospital

๐Ÿ‡ธ๐Ÿ‡ช

Stockholm, Sweden

Stockholm Southern Hospital (Sรถdersjukhuset)

๐Ÿ‡ธ๐Ÿ‡ช

Stockholm, Sweden

Dana-Farber Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Cliniques Universitaires Saint-Luc UCL

๐Ÿ‡ง๐Ÿ‡ช

Brussels, Belgium

Institut Jules Bordet

๐Ÿ‡ง๐Ÿ‡ช

Brussels, Belgium

University Hospitals Leuven, KU Leuven

๐Ÿ‡ง๐Ÿ‡ช

Leuven, Belgium

Cancer Institute ICESP

๐Ÿ‡ง๐Ÿ‡ท

Sรฃo Paulo, Brazil

Bergonie Institute

๐Ÿ‡ซ๐Ÿ‡ท

Bordeaux, France

Leon Berard Cancer Center

๐Ÿ‡ซ๐Ÿ‡ท

Lyon, France

Hopital Saint Louis

๐Ÿ‡ซ๐Ÿ‡ท

Paris, France

Institut Curie

๐Ÿ‡ซ๐Ÿ‡ท

Paris, France

Centre Henri Becquerel

๐Ÿ‡ซ๐Ÿ‡ท

Rouen, France

Institut Gustave Roussy

๐Ÿ‡ซ๐Ÿ‡ท

Villejuif, France

Sharett Institute of Oncology - Hadassah Hebrew University Medical Center

๐Ÿ‡ฎ๐Ÿ‡ฑ

Jerusalem, Israel

Sheba Medical Center

๐Ÿ‡ฎ๐Ÿ‡ฑ

Tel Aviv, Israel

Tel Aviv Sourasky Medical Center

๐Ÿ‡ฎ๐Ÿ‡ฑ

Tel Aviv, Israel

Oncological Center CRO

๐Ÿ‡ฎ๐Ÿ‡น

Aviano, Italy

Azienda Ospedaliera "Papa Giovanni XXIII"

๐Ÿ‡ฎ๐Ÿ‡น

Bergamo, Italy

Candiolo Cancer Center (IRCCS)

๐Ÿ‡ฎ๐Ÿ‡น

Candiolo, Italy

European Institute of Oncology

๐Ÿ‡ฎ๐Ÿ‡น

Milan, Italy

Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia

๐Ÿ‡ฎ๐Ÿ‡น

Modena, Italy

IOV (Istituto Oncologico Veneto)

๐Ÿ‡ฎ๐Ÿ‡น

Padova, Italy

IRCCS Policlinico San Matteo

๐Ÿ‡ฎ๐Ÿ‡น

Pavia, Italy

AOU Policlinico Umberto I

๐Ÿ‡ฎ๐Ÿ‡น

Roma, Italy

Instituto Nacional de Cancerologia

๐Ÿ‡ฒ๐Ÿ‡ฝ

Mexico City, Mexico

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology

๐Ÿ‡ต๐Ÿ‡ฑ

Warsaw, Poland

Hospital de Santa Maria and Instituto de Medicina Molecular of the Faculty of Medicine of the University of Lisbon

๐Ÿ‡ต๐Ÿ‡น

Lisbon, Portugal

Vall D'Hebron University Hospital

๐Ÿ‡ช๐Ÿ‡ธ

Barcelona, Spain

Hospital Universitari Son Espases Palma

๐Ÿ‡ช๐Ÿ‡ธ

Palma De Mallorca, Spain

INCLIVA, University Hospital of Valencia

๐Ÿ‡ช๐Ÿ‡ธ

Valencia, Spain

Oncology Institute of Southern Switzerland

๐Ÿ‡จ๐Ÿ‡ญ

Lugano, Switzerland

ยฉ Copyright 2025. All Rights Reserved by MedPath